These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy. Disertori M; Quintarelli S; Mazzola S; Favalli V; Narula N; Arbustini E Europace; 2013 Dec; 15(12):1693-701. PubMed ID: 23946316 [TBL] [Abstract][Full Text] [Related]
13. Baroreflex sensitivity assessed with the sequence method is associated with ventricular arrhythmias in patients implanted with a defibrillator for the primary prevention of sudden cardiac death. Garcia R; Degand B; Fraty M; Le Marcis V; Bidegain N; Laude D; Tavernier M; Le Gal F; Hadjadj S; Saulnier PJ; Ragot S Arch Cardiovasc Dis; 2019 Apr; 112(4):270-277. PubMed ID: 30670362 [TBL] [Abstract][Full Text] [Related]
14. Ongoing Risk of Ventricular Arrhythmias and All-Cause Mortality at Implantable Cardioverter Defibrillator Generator Change: A Systematic Review and Meta-Analysis. Yuyun MF; Erqou SA; Peralta AO; Hoffmeister PS; Yarmohammadi H; Echouffo-Tcheugui JB; Martin DT; Joseph J; Singh JP Circ Arrhythm Electrophysiol; 2021 Mar; 14(3):e009139. PubMed ID: 33554611 [TBL] [Abstract][Full Text] [Related]
17. Disrupting the Approach to Sudden Cardiac Death: From Vulnerable Ejection Fraction to Vulnerable Patient. Chugh SS Circulation; 2018 Jan; 137(1):7-9. PubMed ID: 29279335 [No Abstract] [Full Text] [Related]
18. Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients With Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator. Packer M Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e007430. PubMed ID: 31159583 [No Abstract] [Full Text] [Related]
19. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy. Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359 [TBL] [Abstract][Full Text] [Related]
20. Current challenges in sudden cardiac death prevention. Corrado D; Zorzi A; Vanoli E; Gronda E Heart Fail Rev; 2020 Jan; 25(1):99-106. PubMed ID: 31346843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]